Daniel Link, MD

Daniel Link, MD

Bone Marrow Transplant Specialist, Medical Oncologist

Primary Academic Title

Deputy Director, Alvin J. Siteman Cancer Center; Chief, Division of Oncology; Alan A. and Edith L. Wolff Professor of Medicine, Division of Oncology, Washington University School of Medicine

Clinical Expertise

Hematopoietic stem cell transplantation, leukemia, neutropenia

Research Interest

Molecular mechanisms controlling hematopoietic cell proliferation and differentiation; granulocyte colony stimulating factor receptor signal transduction and biological activities.

Education

  • 1985: MD, University of Wisconsin, Madison

Training

  • 1985 - 1988: Intern and resident, internal medicine, Washington University, St. Louis
  • 1988 - 1992: Fellow, hematology/oncology, Washington University

Board Certification

  • 1989: American Board of Internal Medicine
  • 1990: American Board of Internal Medicine, hematology

Selected Research Publications

ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.
  • Sande CM, Chen S, Mitchell DV, [...] Link DC, [...] Babushok DV
  • J Clin Invest 2025
Are TP53 mutations all alike?
  • Wong TN, Link DC
  • Hematology Am Soc Hematol Educ Program 2024
The Clonal Hematopoiesis-associated Gene Srcap Plays an Essential Role in Hematopoiesis.
  • Wong TN, Mychalowych A, Feldpausch ER, [...] Link DC
  • bioRxiv 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.
  • Tran D, Beeler JS, Liu J, [...] Link DC, [...] Bolton KL
  • Clin Cancer Res 2024
Genomic landscape of TP53-mutated myeloid malignancies.
  • Abel HJ, Oetjen KA, Miller CA, [...] Link DC
  • Blood Adv 2023
IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry.
  • Lu P, Oetjen KA, Bender DE, [...] Link DC, Thorek DLJ
  • Nat Commun 2023
Clonal Hematopoiesis and Risk of Incident Lung Cancer.
  • Tian R, Wiley B, Liu J, [...] Link DC, [...] Cao Y
  • J Clin Oncol 2023
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
  • Kramer MH, Zhang Q, Sprung R, [...] Link DC, [...] Ley TJ
  • Blood 2022
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Link DC, [...] Welch JS
  • Haematologica 2022

View All Publications

Contact Information

  • Washington University Medical Campus

    Gary C. Werths Building at Siteman Cancer Center
    4500 Forest Park Avenue
    Saint Louis, MO 63108

    Center for Advanced Medicine at Siteman Cancer Center
    4921 Parkview Place
    Saint Louis, MO 63110

    Parkview Tower
    1 Parkview Place
    Saint Louis, MO 63110

    S. Lee Kling Proton Therapy Center
    224 Euclid Ave.
    Saint Louis, MO 63110

    Siteman Kids at St. Louis Children’s Hospital
    1 Children's Place
    St. Louis, MO 63110

Phone Numbers

Request an appointment